Drugs / Doxorubicine pegylated
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00600977 | Mar 2002 → Oct 2006 | acute lymphoblastic leukemia | French Innovative Leukemia Organisation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Doxorubicine pegylated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00600977 ↗ |
| Route | Intravenous | “Intraveinous Liposomal Pegylated Doxorubicin” NCT00600977 ↗ |